121952-97-4 | 5-Benzyl-thiazol-2-ylamine

Packsize	Purity	Availability	Price	Discounted Price
250mg	95%	in stock	$49.00	$35.00
1g	95%	in stock	$163.00	$114.00
5g	95%	in stock	$465.00	$325.00
10g	95%	in stock	$643.00	$450.00
25g	95%	in stock	$1,288.00	$902.00

Description

• Catalog Number: AA54831
• Chemical Name: 5-Benzyl-thiazol-2-ylamine
• CAS Number: 121952-97-4
• Molecular Formula: C10H10N2S
• Molecular Weight: 190.2648
• MDL Number: MFCD00547831
• SMILES: Nc1ncc(s1)Cc1ccccc1

Computed Properties

• Complexity: 157
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 13
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 2
• XLogP3: 2.6

Upstream Synthesis Route

5-Benzylthiazol-2-amine is a valuable chemical compound widely utilized in chemical synthesis processes. This compound serves as a versatile building block in organic chemistry due to its unique structure and reactivity. In the realm of medicinal chemistry, 5-Benzylthiazol-2-amine has been employed in the synthesis of various pharmaceutical agents and drug candidates. Its presence in the molecular structure of these compounds imparts desirable biological activities and enhances their pharmacological properties.Furthermore, 5-Benzylthiazol-2-amine is a key intermediate in the production of specialized materials such as polymers, dyes, and agrochemicals. Its incorporation into these products enables the fine-tuning of their physical and chemical properties, leading to enhanced performance and efficiency. Additionally, this compound is utilized in the development of novel catalysts and ligands for organic transformations, enabling the synthesis of complex molecules with high selectivity and efficiency.Overall, the application of 5-Benzylthiazol-2-amine in chemical synthesis spans across various industries, driving innovation and progress in the field of organic chemistry. Its versatility and reactivity make it a crucial component in the creation of valuable compounds with diverse functionalities and applications.

Literature

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101